Literature DB >> 34862656

Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis.

Shuai Ren1,2, Pengpeng Cai1,3, Yaqian Liu1, Tianpei Wang1, Yan Zhang1, Qian Li1, Yuanliang Gu1, Liqin Wei2, Caiwang Yan1,4, Guangfu Jin1,5.   

Abstract

BACKGROUND AND AIM: Helicobacter pylori (H. pylori) infection rates have been changing with different populations and geographic areas. We systematically evaluated the longitudinal trends in H. pylori prevalence in China over the past decades.
METHODS: We performed a systematic review of literature reporting the prevalence of H. pylori infection in mainland China from 1990 to 2019 in the PubMed and China National Knowledge Infrastructure databases. We conducted a meta-analysis of qualified studies using a random effects model to estimate the pooled prevalence with a 95% confidence interval (95%CI).
RESULTS: A total of 412 eligible studies with 1 377 349 subjects were included. The pooled H. pylori prevalence was 44.2% (95%CI: 43.0-45.5%) in mainland China, with an estimated 589 million individuals infected with H. pylori. The prevalence was relatively high in the Northwest (51.8%, 95%CI: 47.5-56.1%), East (47.7%, 95%CI: 45.4-50.0%), and Southwest China (46.6%, 95%CI: 42.1-51.1%). The prevalence significantly decreased from 58.3% (95%CI: 50.7-65.5%) in the period 1983-1994 to 40.0% (95%CI: 38.2-41.8%) in the period 2015-2019. The prevalence increased with age, ranging from 28.0% (95%CI: 23.9-32.5%) in children and adolescents to 46.1% (95%CI: 44.5-47.6%) in adults.
CONCLUSION: Although the burden of H. pylori infections is still huge in China, the infection rate has been decreasing over the past decades. Targeted H. pylori eradication strategies may be considered in areas or populations with a high incidence of gastric cancer.
© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  China; Helicobacter pylori; epidemiology; meta-analysis; prevalence

Mesh:

Year:  2021        PMID: 34862656     DOI: 10.1111/jgh.15751

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Effect of aqueous extract of seed of broccoli on inflammatory cytokines and Helicobacter pylori infection: a randomized, double-blind, controlled trial in patients without atrophic gastritis.

Authors:  Kai Guo; Lei Wang; Jinli Mahe; Liansheng Li; Shaojiang Jiao; Haiyan Wang; Yanru Xie; Xiaoming Liu; Xuejiao Zeng; Xiaobin Hu; Lipeng Jing
Journal:  Inflammopharmacology       Date:  2022-07-13       Impact factor: 5.093

Review 2.  Current guidelines for Helicobacter pylori treatment in East Asia 2022: Differences among China, Japan, and South Korea.

Authors:  Jun-Hyung Cho; So-Young Jin
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

Review 3.  Treatment of Pediatric Helicobacter pylori Infection.

Authors:  Hung-Hsiang Lai; Ming-Wei Lai
Journal:  Antibiotics (Basel)       Date:  2022-06-01

4.  Distribution characteristics of the sabA, hofC, homA, homB and frpB-4 genes of Helicobacter pylori in different regions of China.

Authors:  Mengyang Fang; Zhijing Xue; Lihua He; Yuanhai You; Yanan Gong; Dongjie Fan; Lu Sun; Kangle Zhai; Yaming Yang; Jianzhong Zhang
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

5.  Gastric mucosal precancerous lesions in Helicobacter pylori-infected pediatric patients in central China: A single-center, retrospective investigation.

Authors:  Miao Yu; Jing Ma; Xiao-Xia Song; Qiao-Qiao Shao; Xue-Chun Yu; Muhammad Noman Khan; Ya-Bin Qi; Ruo-Bing Hu; Pei-Ru Wei; Wei Xiao; Bai-Ling Jia; Yan-Bo Cheng; Ling-Fei Kong; Chuan-Liang Chen; Song-Ze Ding
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

Review 6.  Relationship between Helicobacter pylori infection and gastrointestinal microecology.

Authors:  Wenting Xu; Liming Xu; Chengfu Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

7.  Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of Helicobacter pylori.

Authors:  Xiaofen Jia; Qiuyue Huang; Miaomiao Lin; Yingming Chu; Zongming Shi; Xuezhi Zhang; Hui Ye
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

8.  Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.

Authors:  Xiaoqiong Tang; Zhonghua Wang; Yalin Shen; Xiaona Song; Mohammed Benghezal; Barry J Marshall; Hong Tang; Hong Li
Journal:  BMC Microbiol       Date:  2022-08-13       Impact factor: 4.465

9.  Pharmacological and molecular analysis of the effects of Huangqi Jianzhong decoction on proliferation and apoptosis in GES-1 cells infected with H. pylori.

Authors:  Jingnan Hu; Tao He; Jianfang Liu; Sujie Jia; Bolin Li; Weichao Xu; Man Liao; Lifang Guo
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.